Market Participants Love Strawman Issues
Insights - Market Participant Love Strawman Issues
Read nowAuthor Archives: Jake King
ASCO Has Wrapped and EHA Is Underway
Research - ASCO has wrapped up and EHA is underway this weekend in Copenhagen. Lets take a quick look at the state of the markets as biotech … Continue Reading
Premium
ASCO 2016 Trade Updates
Research - Ariad Pharmaceuticals (ARIA) reported Monday morning updated results from the ALTA trial, testing brigatinib in ALK+ non-small cell lung cancer patients who had experienced disease … Continue Reading
Premium
Buying the Sarepta Dip Works, Yet Again
Research - Sarepta Therapeutics (SRPT) announced this evening that as part of its ongoing eteplirsen review, the FDA has requested that Sarepta provide dystrophin data (measured by … Continue Reading
Premium
No One Wants Rockwell’s Triferic, Apparently
Insights - Rockwell Medical (RMTI) reported sales of Triferic in the first quarter of … none. Rockwell sold $200K worth of Triferic in the fourth quarter of … Continue Reading
Read now
Ariad’s Strategic Review, Step Two
Research - Ariad Pharmaceuticals (ARIA) took the second step in its ongoing strategic restructuring on Monday, announcing the sale of its European unit and rights to Iclusig … Continue Reading
Read now
Simply Sit on That Sarepta Trade, and More Updates
Research - The NASDAQ Biotech Index Fund (IBB) failed to break out from $285 last week (discussed two weeks ago in our webinar) and subsequently lost key … Continue Reading
Premium